Literature DB >> 11054235

Apoptosis, proliferation, and p27 expression during vessel wall healing: time course study in a mouse model of transluminal femoral artery injury.

E D Reis1, M Roqué, C Cordon-Cardo, M Drobnjak, V Fuster, J J Badimon.   

Abstract

OBJECTIVE: The balance between cell death and proliferation in the vessel wall influences neointimal formation, remodeling, and eventual luminal narrowing after arterial injury. In this study, the time course of apoptosis, proliferation, and expression of p27-a critical regulator of cell-cycle progression-is characterized in a mouse model of transluminal arterial injury associated with substantial neointimal formation.
METHODS: C57BL/6 mice underwent bilateral femoral artery injury by passage of an angioplasty guidewire. Expression of p27, Ki67 proliferative index, and apoptosis, as well as histomorphometry, were analyzed in cross sections of uninjured arteries and arteries harvested at different time intervals after injury.
RESULTS: In the uninjured arteries, no apoptotic cells were detected, and p27 and Ki67 were expressed in less than 5% of medial cells. After injury, apoptosis increased markedly in medial smooth muscle cells from 1 to 24 hours and decreased gradually thereafter. Ki67 proliferative index increased after 1 week, peaked at 2 weeks in both the media and neointima, and decreased thereafter. p27 expression was undetectable from 1 to 48 hours, and increased gradually from 1 to 4 weeks. Well-developed neointima was present at 2 and 4 weeks.
CONCLUSIONS: In vivo injury to the mouse femoral artery evokes a rapid apoptotic response and downregulation of p27, followed by gradual increase in proliferation. During later phases of arterial repair, p27 expression increases while a shift of proliferation rates toward baseline occurs. Future experiments using this model in genetically modified mice may help identify specific cell-cycle regulatory molecules as therapeutic targets for control of pathologic arterial healing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054235     DOI: 10.1067/mva.2000.109763

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

Review 1.  The COP9 signalosome and vascular function: intriguing possibilities?

Authors:  Douglas S Martin; Xuejun Wang
Journal:  Am J Cardiovasc Dis       Date:  2015-03-20

2.  Central role of RAGE-dependent neointimal expansion in arterial restenosis.

Authors:  Taichi Sakaguchi; Shi Fang Yan; Shi Du Yan; Dmitri Belov; Ling Ling Rong; Monica Sousa; Martin Andrassy; Steven P Marso; Stephan Duda; Bernd Arnold; Birgit Liliensiek; Peter P Nawroth; David M Stern; Ann Marie Schmidt; Yoshifumi Naka
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma.

Authors:  Randolph Hutter; Li Huang; Walter S Speidl; Chiara Giannarelli; Paul Trubin; Gerhard Bauriedel; Mary E Klotman; Valentin Fuster; Juan J Badimon; Paul E Klotman
Journal:  Circulation       Date:  2013-09-16       Impact factor: 29.690

4.  Adenosine Attenuates Human Coronary Artery Smooth Muscle Cell Proliferation by Inhibiting Multiple Signaling Pathways That Converge on Cyclin D.

Authors:  Raghvendra K Dubey; Jürgen Fingerle; Delbert G Gillespie; Zaichuan Mi; Marinella Rosselli; Bruno Imthurn; Edwin K Jackson
Journal:  Hypertension       Date:  2015-09-28       Impact factor: 10.190

5.  Delayed wound healing in sacrococcygeal pilonidal sinus coincides with an altered collagen composition.

Authors:  Marcel Binnebösel; Karsten Junge; Robert Schwab; Albert Antony; Volker Schumpelick; Uwe Klinge
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

6.  The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells.

Authors:  Natalia F Smirnova; Coralie Fontaine; Mélissa Buscato; Adrien Lupieri; Alexia Vinel; Marie-Cécile Valera; Maeva Guillaume; Nicole Malet; Jean-Michel Foidart; Isabelle Raymond-Letron; Francoise Lenfant; Pierre Gourdy; Benita S Katzenellenbogen; John A Katzenellenbogen; Muriel Laffargue; Jean-Francois Arnal
Journal:  Circ Res       Date:  2015-08-27       Impact factor: 17.367

7.  Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma.

Authors:  Katsunori Matsushita; Shogo Kobayashi; Hirofumi Akita; Masamitsu Konno; Ayumu Asai; Takehiro Noda; Yoshifumi Iwagami; Tadafumi Asaoka; Kunihito Gotoh; Masaki Mori; Yuichiro Doki; Hidetoshi Eguchi; Hideshi Ishii
Journal:  Cancer Rep (Hoboken)       Date:  2021-11-24

8.  TGF-β/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A.

Authors:  X Shi; L-W Guo; S M Seedial; Y Si; B Wang; T Takayama; P A Suwanabol; S Ghosh; D DiRenzo; B Liu; K C Kent
Journal:  Cell Death Dis       Date:  2014-07-10       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.